Ru-bo Cao
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Treatment outcomes of fruquintinib combined with PD-1 inhibitors in advanced colorectal cancer: a reconstructed patient-level meta-analysis of retrospective real-world studies.
Journal: BMC cancer
Published: April 06, 2026
The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies.
Journal: Medicine
Published: August 02, 2024
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies.
Journal: Frontiers in endocrinology
Published: February 13, 2024
Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies.
Journal: Frontiers in endocrinology
Published: November 27, 2023
The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis.
Journal: Oral oncology
Published: November 19, 2019
Application of dynamic monitoring of genomic profiles in non-small cell lung cancer: A case report.
Journal: Medicine
Published: December 22, 2018
Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
Journal: International journal of cancer
Published: July 23, 2018
Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1.
Journal: Oncotarget
Published: November 01, 2016
Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.
Journal: Molecular medicine reports
Published: October 14, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026